pargyline has been researched along with Acute Disease in 3 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Acute Disease: Disease having a short and relatively severe course.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pickar, D | 1 |
Murphy, DL | 1 |
Cohen, RM | 1 |
Campbell, IC | 1 |
Lipper, S | 1 |
Dvorák, J | 1 |
Trojan, S | 1 |
St'astný, F | 1 |
Price, J | 1 |
Hopkinson, G | 1 |
1 review available for pargyline and Acute Disease
Article | Year |
---|---|
Mono-amine oxidase inhibitors and schizophrenia.
Topics: Acute Disease; Amines; Amphetamine; Chronic Disease; Hallucinogens; Humans; Iproniazid; Isoniazid; M | 1968 |
1 trial available for pargyline and Acute Disease
Article | Year |
---|---|
Selective and nonselective monoamine oxidase inhibitors: behavioral disturbances during their administration to depressed patients.
Topics: Acute Disease; Adult; Affective Disorders, Psychotic; Bipolar Disorder; Clorgyline; Depressive Disor | 1982 |
1 other study available for pargyline and Acute Disease
Article | Year |
---|---|
[The effect of pentobarbital and pargyline on the development of acute experimental intracranial hypertension in chick embryos].
Topics: Acute Disease; Animals; Asphyxia; Brain Edema; Chick Embryo; Intracranial Pressure; Pargyline; Pento | 1987 |